Related Experiment Video
Updated: Jun 18, 2026
07:08
Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
Synthesis and Biochemical Characterization of Investigational Pyrazolopyrimidine-Based Allosteric KRAS Modulators.
Cynthia V Pagba1, Kasuni Dilsha2, Rakshya Ojha2
1Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, Texas 77030, United States.
ACS Medicinal Chemistry Letters
|June 17, 2026
Summary
Researchers developed new KRAS inhibitors with high binding affinity but variable cell growth inhibition. These compounds are valuable tools for studying KRAS mutations and cancer drug discovery.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Oncology
Background:
- KRAS is a key oncogene implicated in various cancers.
- Developing effective KRAS inhibitors remains a significant challenge in cancer therapy.
- Previous pyrazolopyrimidine-based inhibitors showed promise but required optimization.
Purpose of the Study:
- To synthesize and biochemically characterize novel pyrazolopyrimidine derivatives.
- To enhance binding affinity and inhibitory activity against wild-type and mutant KRAS.
- To evaluate the therapeutic potential of these derivatives in cancer cells.
Main Methods:
- Chemical synthesis of pyrazolopyrimidine core derivatives.
- Biophysical measurements to assess KRAS binding affinity.
- Cell proliferation assays to determine inhibitory potency against cancer cells.
- Structure-activity relationship (SAR) studies.
Main Results:
- Dozens of novel derivatives were synthesized and characterized.
- Many compounds demonstrated significantly increased binding affinity to KRAS (nanomolar range).
- Enhanced binding affinity did not consistently correlate with improved cell growth inhibition.
- Compounds showed low micromolar inhibitory activity against multiple KRAS mutant cancer cells.
Conclusions:
- The synthesized derivatives represent valuable chemical probes for KRAS research.
- These compounds can serve as starting points for further optimization in drug discovery.
- Further structure-activity relationship studies are warranted to develop more potent KRAS inhibitors.
Related Concept Videos
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...